Repligen Corporation (RGEN)

Healthcare · Medical Instruments Supplies · NASDAQ

Repligen Corporation (RGEN) is a Healthcare company in the Medical Instruments Supplies industry. It has a market capitalization of $9.25B, a trailing price-to-earnings ratio of 83.2 and a free-cash-flow yield of 1.0%. Over the most recent reported fiscal year, revenue grew 16.4% and free cash flow per share fell 36.4%.

Market cap	$9.25B
Trailing P/E	83.2
FCF yield	1.0%
Revenue growth (YoY)	+16.4%
EPS growth (YoY)	+15.5%
FCF/share growth (YoY)	-36.4%
Exchange	NASDAQ
Sector	Healthcare
Industry	Medical Instruments Supplies

Explore live RGEN data on Nama Insights →

Recent Congressional trades

Repligen Corporation trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member	Chamber	Trade	Amount	Disclosed
Lisa McClain	House	Sell	$1,001 - $15,000	Nov 1, 2025
Lisa McClain	House	Sell	$1,001 - $15,000	Nov 1, 2025
Lisa McClain	House	Buy	$1,001 - $15,000	Aug 13, 2025